The TGA said it first identified the potential association between GLP-1 drugs and NAION in 2024 when a study was published in the Journal of the American Medical Association (JAMA) Ophthalmology
Table of Contents How GLP-1 Medications Work in Your Body Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications used primarily for managing type 2 diabetes and, increasingly, for weight management
If you are eligible, you may be asked to complete lab tests, including a metabolic test
Balance Macronutrients: They teach you how to balance protein, fats, and carbohydrates to fuel your body, maintain energy levels, and support your strength training efforts
Bnh Parkinson Parkinson l bnh thoi ha thn kinh mn tnh, nh hng n h thn kinh vn ng do mt cc t bo thn kinh sn xut dopamine
A high level of TMAO is thought to contribute to atherosclerosis, leading to a long-term risk of CVDs and poor prognosis in patients (62) ( Figure 3 )